Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 4/20 | 0.60 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.60 |
| ▸ | BRS3 | P32247 | 1/20 | 0.44 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.43 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.43 |
| ▸ | CACNA1I | Q9P0X4 | 3/20 | 0.43 |
| ▸ | BRD4 | O60885 | 3/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8563681 | 1.00 | MTNR1A (0.60) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8563680 | 1.00 | MTNR1A (0.60) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL10689632 | 0.82 | MTNR1A (0.62) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8563909 | 0.81 | MTNR1A (0.53) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8563914 | 0.81 | MTNR1A (0.53) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8560060 | 0.81 | MTNR1A (0.64) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8560054 | 0.81 | MTNR1A (0.64) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL8560058 | 0.81 | MTNR1A (0.64) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H | |
| SCHEMBL31021724 | 0.80 | HPGD (0.56) | — | |
| SCHEMBL25740830 | 0.78 | MTNR1A (0.56) | MTNR1AMTNR1BBRS3CACNA1GCACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5719141-A | HYPOTENSIVE AGENTS | NOVARTIS CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0702004-A2 | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives | CIBA-GEIGY AG (CH) | 1996-03-20 | — | — | EP | disclosed |